Testing effectiveness (Phase 2)Study completedNCT03935204
What this trial is testing
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 627